Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Sanuwave reported another quarter of record results in the third quarter, delivering revenue of $11.5 million, a 22% increase year-over-year. While the headline...
— Sean Kirkwood
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Sanuwave Health, Inc.
More institutional theses from SRK Capital
Vaso Corporation is executing an unusual SPAC merger to uplist from OTCQX to Nasdaq, implying a pro forma value of $0.93 per share compared to its recent $0.28 market price. The structural transaction...
Innovative Solutions & Support offers ~20% organic growth supplemented by a high-return bolt-on acquisition strategy that leverages unutilized manufacturing capacity. Its recent acquisition...
Sigmatron International trades at under one-third of book value and 3x normalized earnings due to current cyclical weakness in consumer electronics manufacturing. Significant working capital...